ÂÜÀòÂÒÂ×

Kapil Dhingra, MD has more than 30 years of experience in oncology clinical research and drug development within the biotechnology and pharmaceutical industries.

He previously served as Vice President, Head of the Oncology Disease Biology Leadership Team and Head of Oncology Clinical Development at Hoffmann-La Roche, during which time he led numerous drug approvals. Prior to Roche, he worked in the oncology clinical development group at Eli Lilly and Company. He is now a board member of several successful biotechnology companies.

Dr Dhingra obtained his M.B.B.S. degree from the All India Institute of Medical Sciences in New Delhi, India. He completed his residency in internal medicine at Lincoln Medical and Mental Health Center, New York Medical College, and completed his fellowship in hematology and oncology at Emory University School of Medicine.